KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCash from Discontinued OperationsCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Change in Account Payables: 2010-2025

Historic Change in Account Payables for TherapeuticsMD (TXMD) over the last 15 years, with Sep 2025 value amounting to -$87,000.

  • TherapeuticsMD's Change in Account Payables fell 195.60% to -$87,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $29,000, marking a year-over-year increase of 106.28%. This contributed to the annual value of $231,000 for FY2024, which is 110.82% up from last year.
  • Latest data reveals that TherapeuticsMD reported Change in Account Payables of -$87,000 as of Q3 2025, which was down 150.00% from $174,000 recorded in Q2 2025.
  • In the past 5 years, TherapeuticsMD's Change in Account Payables ranged from a high of $5.0 million in Q3 2021 and a low of -$10.8 million during Q1 2021.
  • In the last 3 years, TherapeuticsMD's Change in Account Payables had a median value of $4,000 in 2024 and averaged -$172,636.
  • Per our database at Business Quant, TherapeuticsMD's Change in Account Payables plummeted by 946.84% in 2023 and then skyrocketed by 4,250.00% in 2025.
  • Over the past 5 years, TherapeuticsMD's Change in Account Payables (Quarterly) stood at $414,000 in 2021, then plummeted by 80.92% to $79,000 in 2022, then crashed by 946.84% to -$669,000 in 2023, then skyrocketed by 103.59% to $24,000 in 2024, then plummeted by 195.60% to -$87,000 in 2025.
  • Its last three reported values are -$87,000 in Q3 2025, $174,000 for Q2 2025, and -$82,000 during Q1 2025.